Otis W. Brawley - Mar 31, 2025 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role
Director
Signature
/s/ Matthew Lang, as Attorney-in-Fact
Stock symbol
LYEL
Transactions as of
Mar 31, 2025
Transactions value $
$19,958
Form type
4
Date filed
4/2/2025, 03:46 PM
Previous filing
Mar 18, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYEL Common Stock Purchase $20K +35.6K $0.56 35.6K Mar 31, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.